Preventing post-operative cognitive decline
Phase of Trial: Phase IV
Latest Information Update: 27 Dec 2007
At a glance
- Drugs Donepezil (Primary)
- Indications Mild cognitive impairment
- Focus Therapeutic Use
- Sponsors Pfizer
- 27 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 10 Dec 2005 New trial record.